Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients

MeSH terms

• Adverse Drug Reaction Reporting Systems / standards*
• Adverse Drug Reaction Reporting Systems / statistics & numerical data
• Aged
• Antineoplastic Agents, Hormonal / adverse effects*
• Antineoplastic Agents, Hormonal / therapeutic use
• Autopsy
• Cause of Death
• Data Collection / methods
• Data Interpretation, Statistical*
• Death Certificates
• Endometrial Neoplasms / chemically induced*
• Endometrial Neoplasms / mortality
• Estrogen Antagonists / adverse effects*
• Estrogen Antagonists / therapeutic use
• Female
• Humans
• Informed Consent
• Medical Records / standards
• Middle Aged
• National Institutes of Health (U.S.)
• Publishing
• Randomized Controlled Trials as Topic / statistics & numerical data
• Risk Assessment
• Tamoxifen / adverse effects*
• Tamoxifen / therapeutic use
• United States